Brewin Dolphin Wealth Management LTD Cel Sci Corp Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Cel Sci Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 1,500 shares of CVM stock, worth $1,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$1,095
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CVM
# of Institutions
71Shares Held
6MCall Options Held
27.1KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA2.41MShares$1.76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY775KShares$565,5330.0% of portfolio
-
Geode Capital Management, LLC Boston, MA613KShares$447,3880.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ432KShares$315,4520.0% of portfolio
-
State Street Corp Boston, MA194KShares$141,2600.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $31.7M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...